Summary & Overview
CPT 47371: Laparoscopic Cryoablation of Liver Tumor
CPT code 47371 denotes laparoscopic cryosurgical ablation of one or more liver tumors. The code captures a minimally invasive, laparoscopy-based cryoablation technique used to destroy hepatic tumor tissue. This procedure is clinically significant as a liver-directed treatment option for select patients with primary or metastatic hepatic tumors, offering a potentially organ-preserving alternative to open resection.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, common service settings, and payer coverage considerations. The publication outlines national benchmarks for utilization and reimbursement patterns, summarizes relevant policy and coverage updates affecting ablation services, and clarifies coding and billing considerations related to procedural reporting for laparoscopic cryoablation.
Intended for clinicians, coding professionals, and policy analysts, the report provides actionable reference material on where CPT code 47371 fits within liver-directed therapies, how payers commonly approach coverage, and what documentation elements are typically relevant for claims processing. Data not available in the input are explicitly noted where applicable.
Billing Code Overview
CPT code 47371 describes a laparoscopic cryosurgical ablation of one or more liver tumors, in which the provider uses cryosurgery (freezing) via a laparoscope to destroy hepatic tumor tissue. The procedure is a form of minimally invasive tumor ablation performed using laparoscopic access and cryoablation techniques.
Service type: Surgical ablative procedure (laparoscopic cryoablation)
Typical site of service: Ambulatory surgical center or hospital operating room with laparoscopic capability, where general anesthesia and intraoperative imaging support are available.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 60-year-old with a history of primary hepatocellular carcinoma or metastatic colorectal cancer to the liver who presents for minimally invasive tumor-directed therapy. The patient has one to several hepatic lesions identified on cross-sectional imaging and multidisciplinary tumor board review deems percutaneous or open resection unsuitable due to lesion location, comorbidity, or distribution. The operative workflow for laparoscopic cryoablation (47371) includes preoperative imaging review, general anesthesia, laparoscopic port placement, intraoperative laparoscopic ultrasound to localize tumors, insertion of cryoprobes under direct visualization, controlled freeze-thaw cycles to achieve cytotoxic ice-ball margins, intraoperative assessment for bleeding or bile leak, and laparoscopic removal of probes with hemostasis. Postoperative care includes recovery in PACU, serial liver function testing, pain control, and follow-up imaging to assess treatment response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician’s professional interpretation or service separate from technical facility resources. |
50 |